Reducing intersectional cancer disparities through education
- PMID: 40625790
- PMCID: PMC12230416
- DOI: 10.1016/j.lana.2025.101086
Reducing intersectional cancer disparities through education
Conflict of interest statement
NYL serves on the advisory boards (consultant) with Merck, Merck Serono, Nanobiotix, Galera, LEO Pharma scientific advisory board, and GSK. NYL has served as an invited speaker for Shanghai JoAnn Medical Technology Co., Ltd., Yingming Consulting, the RANZCR ASM Australia 2022 Targeting Cancer Meeting (funded by Varian), and SYS Cancer Center conference (funded by Suzhou Liangyihui Network Technology Co., Ltd.). PI received research grants from Incyte (to the institution) and has participated in the Advisory Board of AstraZeneca, Novocure, Johnson and Johnson, BioConvergent Health, Pfizer, and NGM Biosciences. All other authors have no conflicts-of-interest to declare.
References
-
- The state of cancer disparities in the United States | research highlights. https://www.cancer.org/research/acs-research-highlights/cancer-health-di... [cited 2025 Jan 24]. Available from:
-
- Liptzin D.R., Gleason M.C., Cicutto L.C., et al. Developing, implementing, and evaluating a school-centered asthma program: step-up asthma program. J Allergy Clin Immunol Pract. 2016;4(5):972–979.e1. - PubMed
-
- Eagle T.F., Gurm R., Smith C.A., et al. A middle school intervention to improve health behaviors and reduce cardiac risk factors. Am J Med. 2013;126(10):903–908. - PubMed
LinkOut - more resources
Full Text Sources
